Wednesday after President Donald Trump announced tariffs for all trading partners as investors fretted over increased prices ...

At the market, a federal complaint shows investigators found vendors selling controlled substances, including “MDMA, cocaine, ketamine, LSD, marijuana, and psilocybin mushrooms.” ...

A large illicit drug market has been shut down by the Department of Homeland Security and the DEA after a weekend raid on a warehouse in Gresham.

Hims & Hers Health (NYSE: HIMS) stock labored mightily on Wednesday, but in the end, it couldn't top the benchmark S&P 500 ...

The Federal Trade Commission put on hold a lawsuit against pharmacy-benefit manager (PBM) units of UnitedHealth , Cigna and CVS Health over insulin prices after the Trump administration fired two of ...

Novavax ticked up, but remained deep in the red for the year to date. The Federal Trade Commission's lawsuit against three large pharmacy-benefit managers over insulin prices -- Cigna's Express ...

Rising biosimilar adoption, shifting market dynamics, and escalating supply chain vulnerabilities are driving change in ...

A unanimous Supreme Court on Wednesday backed the Food and Drug Administration's refusal to authorize the sale of ...

Arcus Biosciences is a high-risk speculation with major upcoming catalysts, despite stock declines and Gilead's exit from the ...

BrainsWay's Q4 performance was strong, but a rising share count and flat margins have kept the stock from moving higher.

Companies had sued the FDA, saying it unfairly shifted its standards for approving e-cigarette liquids popular with teens.

American companies have raised concerns, noting that price controls have not been increased in line with inflation and do not ...